The efficacy and safety of oxandrolone treatment for patients with severe burns: A systematic review and meta-analysis

被引:45
|
作者
Li, Hui [1 ]
Guo, Yinan [1 ]
Yang, Zhenyu [1 ]
Roy, Mridul [1 ]
Guo, Qulian [1 ]
机构
[1] Cent S Univ, Xiangya Hosp, Dept Anesthesiol, 87 Xiangya Rd, Changsha 410087, Hunan, Peoples R China
关键词
Oxandrolone; Burn; Review; Meta-analysis; TESTOSTERONE ANALOG; NITROGEN-BALANCE; ANABOLIC AGENT; LEAN MASS; CHILDREN; MUSCLE; WEIGHT; PHASE; EPIDEMIOLOGY; PATTERNS;
D O I
10.1016/j.burns.2015.08.023
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective: The objective of this systematic review and meta-analysis was to evaluate the efficacy and safety of using oxandrolone in patients with severe burns. Materials and method: PubMed, Medline, Ovid, Cochrane Library, Elsevier Science, ProQuest, and Springer Link databases were searched. Randomized trials were included, and clinically important measures were selected. The outcomes were pooled with Revman 5.2. Other outcomes that could not be pooled were described in detail. Results: Finally, 15 randomized controlled trials (RCTs) were identified for analysis in this review, including 806 participants. 1. Mortality, infection, and hepatic function: Oxandrolone therapy did not affect mortality (relative risk (RR) = 0.85, 95% confidence interval (CI) = (0.38, 1.89), P = 0.69) or infection (RR = 0.87, (0.69, 1.11), P = 0.26). The two groups (oxandrolone group vs. control group) showed no significant difference in liver dysfunction (RR = 1.15, (0.83, 1.59), P = 0.41). All the 15 RCTs reported no incidence of hepatic insufficiency in controls or treatment groups. 2. In the catabolic phase: Treatment with oxandrolone shortened length of stay by 3.02 (2.37, 3.66) days, donor-site healing time by 4.41 (3.41, 5.41) days, the time between surgical procedures by 0.63 (0.11, 1.16) days, as well as reduced weight loss by 5 (3.70, 6.30) kg and nitrogen loss by 8.19 (6.87, 9.52) g/day, with all P < 0.00001. 3. In the rehabilitative phase: Treatment with oxandrolone shortened the length of stay to 6.45 (4.20, 8.69) days, as well as decreased weight loss by 0.86 (0.76, 0.96) kg/week and reduction of lean body mass by 5% (3.34, 6.66), with all P < 0.00001. 4. Long-term parameters: Oxandrolone treatment led to an additional gain in lean body mass of 3.99% (3.08, 4.89) after 6 months and 10.78% (9.92, 11.64) after 12 months in patients with severe burns, with all P < 0.00001. Conclusion: The treatment of severe burns with oxandrolone is significantly effective without obvious side effects. (C) 2015 Elsevier Ltd and ISBI. All rights reserved.
引用
收藏
页码:717 / 727
页数:11
相关论文
共 50 条
  • [1] Efficacy and safety of blood purification in the treatment of deep burns A systematic review and meta-analysis
    Zhang, Gaofei
    Liu, Wenjun
    Li, Jiamei
    Wang, Di
    Duan, Jianxing
    Luo, Hanxiao
    [J]. MEDICINE, 2021, 100 (05) : E23968
  • [2] Safety and efficacy of vedolizumab in the treatment of patients with moderate to severe Ulcerative Colitis: a systematic review and meta-analysis
    Khorshid, M.
    Alboraie, M.
    Abbas, W.
    Sayed, Z. E.
    El-Nady, M.
    [J]. JOURNAL OF CROHNS & COLITIS, 2021, 15 : S516 - S517
  • [3] Honey in the treatment of burns: a systematic review and meta-analysis of its efficacy
    Wijesinghe, Meme
    Weatherall, Mark
    Perrin, Kyle
    Beasley, Richard
    [J]. NEW ZEALAND MEDICAL JOURNAL, 2009, 122 (1295) : 47 - 60
  • [4] Oxandrolone in the Treatment of Burn Injuries: A Systematic Review and Meta-analysis
    Ring, Justine
    Heinelt, Martina
    Sharma, Shubham
    Letourneau, Sasha
    Jeschke, Marc G.
    [J]. JOURNAL OF BURN CARE & RESEARCH, 2020, 41 (01): : 190 - 199
  • [5] Dupilumab efficacy and safety in patients with moderate to severe asthma: A systematic review and meta-analysis
    Zaazouee, Mohamed Sayed
    Alwarraqi, Asmaa Gomaa
    Mohammed, Yasmine Adel
    Badheeb, Mohamed A.
    Farhat, Abdullah Mohamed
    Eleyan, Mohammed
    Morad, Afnan
    Zeid, Marwa Abdel-Aziz
    Mohamed, Aya Shaban
    AbuEl-Enien, Hazem
    Abdelalim, Ahmed
    Elsnhory, Ahmed Bostamy
    Hrizat, Yasmin S. M.
    Altahir, Nagat Taha
    Atef, Doaa
    Elshanbary, Alaa Ahmed
    Alsharif, Khalaf F.
    Alzahrani, Khalid J.
    Algahtani, Mohammad
    Theyab, Abdulrahman
    Hawsawi, Yousef M.
    Aldarmahi, Ahmed A.
    Abdel-Daim, Mohamed M.
    [J]. FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [6] A Systematic Review and Meta-Analysis: Safety and Efficacy of Cediranib in the Treatment of Cancer Patients
    Wang, Yan
    Cai, Yan
    Wang, Qi-Ming
    [J]. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2023, 2023
  • [7] Efficacy and safety of platelet-rich plasma in the treatment of severe burns A protocol for systematic review and meta analysis
    Chen, Zhao
    Wu, Yuyan
    Turxun, Nurlan
    Shen, Yingjie
    Zhang, Xue
    [J]. MEDICINE, 2020, 99 (45) : E23001
  • [8] Efficacy and safety of tofacitinib in the treatment of patients with active, moderate to severe, Ulcerative Colitis: a systematic review and meta-analysis
    Khorshid, M.
    Dorgham, D.
    Sharobim, A.
    Attia, M.
    Hussein, M.
    Dorgham, N.
    [J]. JOURNAL OF CROHNS & COLITIS, 2021, 15 : S446 - S447
  • [9] Enteral glutamine supplements for patients with severe burns: A systematic review and meta-analysis
    Yue HanYang
    Wang Yu
    Zeng Jun
    Jiang Hua
    Li Wei
    [J]. 中华创伤杂志英文版, 2024, 27 (06)
  • [10] Safety and Efficacy of Adjunctive Therapy With Artesunate in the Treatment of Severe Malaria: A Systematic Review and Meta-Analysis
    Zou, Yuanyuan
    Tuo, Fei
    Zhang, Zhiqi
    Guo, Jiawen
    Yuan, Yueming
    Zhang, Hongying
    Xu, Zhiyong
    Pan, Ziyi
    Tang, Yexiao
    Deng, Changsheng
    Julie, Nadia
    Wu, Wanting
    Guo, Wenfeng
    Li, Changqing
    Huang, Xinan
    Xu, Qin
    Song, Jianping
    Wang, Qi
    [J]. FRONTIERS IN PHARMACOLOGY, 2020, 11